3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
about
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsThe clinical value of large neuroimaging data sets in Alzheimer's diseaseDance Experience and Associations with Cortical Gray Matter Thickness in the Aging PopulationWhere did I put that? Patients with amnestic mild cognitive impairment demonstrate widespread reductions in activity during the encoding of ecologically relevant object-location associations.Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.Alzheimer DiseaseAssociations between hippocampal morphometry and neuropathologic markers of Alzheimer's disease using 7 T MRI.Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's diseaseHippocampal and ventricular changes in Parkinson's disease mild cognitive impairmentRecent advances in imaging Alzheimer's disease.Imaging approaches for dementia.Aberrant hippocampal subregion networks associated with the classifications of aMCI subjects: a longitudinal resting-state study.Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometryMild Cognitive Disorders are Associated with Different Patterns of Brain asymmetry than Normal Aging: The PATH through Life Study.Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.The association between cardiovascular risk factors and progressive hippocampus volume loss in persons with Alzheimer's disease.Neuroimaging measures as endophenotypes in Alzheimer's diseasePattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment.Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measuresRelationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation ProtocolCortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.Mild cognitive impairment: differential atrophy in the hippocampal subfieldsMRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.Mnemonic strategy training improves memory for object location associations in both healthy elderly and patients with amnestic mild cognitive impairment: a randomized, single-blind study.Structural Brain Changes in Early-Onset Alzheimer's Disease Subjects Using the LONI Pipeline Environment.Mnemonic strategy training partially restores hippocampal activity in patients with mild cognitive impairmentIn vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRISurface-based TBM boosts power to detect disease effects on the brain: an N=804 ADNI study.Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies.Plasma microRNA biomarkers for detection of mild cognitive impairment.Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E studySurface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampusRegionally specific increased volume of the amygdala in Williams syndrome: evidence from surface-based modelingMapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.Identify the Atrophy of Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging Using Morphometric MRI Analysis.Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis.ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.Staging Alzheimer's disease progression with multimodality neuroimaging.EFNS task force: the use of neuroimaging in the diagnosis of dementia.
P2860
Q21559700-F75A9333-2A28-4FE8-858B-96A221850568Q28709465-58525A7E-6E93-4FB4-88DA-712979640F9BQ30396059-CFEAB6ED-2F85-40D7-ADD4-A3D0AF1F7533Q30505277-963793CA-D384-4E42-B186-7DCA4FCC5F39Q33388073-F12B8EAF-F111-43DB-81BF-E07AE58EB56DQ33562441-D658D689-9452-462D-955D-D2F8618ABE2AQ33623751-004F40A8-0D6F-4E93-9C5E-0990BFF0C716Q33699736-E512FBED-E32C-4CCB-8B55-A62EB3E6FB36Q33829483-7F4F76B6-E9EF-4BEB-85B5-E68B9525688AQ33946440-887DE8F6-24F0-4121-BD31-9F342A0BB7A2Q34089121-DE44A7B2-16C0-46B0-A726-3822D3D08525Q34117433-DCAD3AEF-0D21-4B5C-A77C-B6A1C762EA0AQ34615211-5BFB7191-4016-4981-82C7-2B679B04B266Q34689650-76922D1E-A721-48B0-8E90-4872FBE78033Q34725320-D0743F0E-DAC3-4AAF-B68D-B45C9C446991Q34795067-72B8F25F-DFE4-406E-B13A-E9D1112116A8Q34924165-222211EA-EC0E-4A4A-AF77-2E45C9D23ABBQ35026669-2058268F-B3D3-4D6E-AE63-43BC10941B60Q35106592-D0231AA3-82A9-4C30-862E-F7F823243A7CQ35143328-2C4B75DC-ABF9-479D-8EF5-E2593B345DEFQ35567430-285CB500-CDE0-46E2-BAEA-B6E443E67C23Q35707941-C4EC6795-28B2-4203-8DA2-DA179EF580A7Q35874019-363058C6-9B4C-4714-BBAF-1125F702C43CQ35930847-3D8733A7-CD5E-4E27-B735-2E8AFBDC31DAQ35947289-0A1DD6EB-8207-48E3-83EA-29F8D6CAE46BQ35957465-AD28694B-7302-40B8-A196-FBBE0A355CFBQ36020584-E45B5BC1-92BB-4E54-A755-CEACE363D9DAQ36080897-994CD991-DC36-4EE1-BC5D-B41D88C06D43Q36087030-F0631A5A-BDDC-4419-8247-396E49B1FBDAQ36315947-2D62BB7D-FC43-4D57-9764-3E34B8B58013Q36380583-1768FBEB-275B-4BA5-BC00-22E91474C794Q36868857-1BA0FBF4-3DFB-4906-941D-D87C6D90728BQ36932677-8BE5184C-2488-447D-8308-F9D0318E4D24Q37117117-43295DD8-B3CA-4EE8-A724-C0AF2B7D2709Q37227438-8B5287A2-2668-4ED0-9DD4-82284BE9FE3BQ37345096-9258A92A-9505-429C-9E1C-BFF529B4680BQ37494206-498CDF13-0589-42CE-B043-37A7771F7F75Q37634708-4C40F185-AAF7-4AA6-8901-AFB5CECBBD0FQ37896258-37C06860-2B6D-4970-911E-D05D9A633E5CQ38035398-154891A7-B4C9-4FEB-982E-FF8999192717
P2860
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@ast
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@en
type
label
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@ast
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@en
prefLabel
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@ast
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@en
P2093
P2860
P50
P356
P1433
P1476
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
@en
P2093
Charleen Zoumalan
Charles S Decarli
Danielle J Harvey
Kristy S Hwang
Leon J Thal
Liana G Apostolova
P2860
P304
P356
10.1002/HBM.20905
P577
2010-05-01T00:00:00Z